百日咳菌感染症(Bordetella Pertussis Infections):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2433CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月28日
◆ページ数:94
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における百日咳菌感染症(Bordetella Pertussis Infections) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 百日咳菌感染症(Bordetella Pertussis Infections)
  - 当レポートの概要
・百日咳菌感染症(Bordetella Pertussis Infections):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014″ provides data on the Bordetella Pertussis Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bordetella Pertussis Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bordetella Pertussis Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bordetella Pertussis Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bordetella Pertussis Infections 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Bordetella Pertussis Infections Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Sanofi 39
Clinical Trial Overview of Sanofi 39
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
Panacea Biotec Limited 47
Clinical Trial Overview of Panacea Biotec Limited 47
PT Bio Farma 48
Clinical Trial Overview of PT Bio Farma 48
LG Life Sciences, Ltd. 49
Clinical Trial Overview of LG Life Sciences, Ltd. 49
Serum Institute of India Limited 50
Clinical Trial Overview of Serum Institute of India Limited 50
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
Daiichi Sankyo Company, Limited 52
Clinical Trial Overview of Daiichi Sankyo Company, Limited 52
Crucell N.V. 53
Clinical Trial Overview of Crucell N.V. 53
Clinical Trial Overview of Top Institutes / Government 54
The National Institute of Allergy and Infectious Diseases 54
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 54
National Institute for Public Health and the Environment 55
Clinical Trial Overview of National Institute for Public Health and the Environment 55
Dalhousie University 56
Clinical Trial Overview of Dalhousie University 56
Statens Serum Institut 57
Clinical Trial Overview of Statens Serum Institut 57
Health Protection Agency 58
Clinical Trial Overview of Health Protection Agency 58
Swedish Institute for Communicable Disease Control 59
Clinical Trial Overview of Swedish Institute for Communicable Disease Control 59
Center for Genetic Engineering and Biotechnology 60
Clinical Trial Overview of Center for Genetic Engineering and Biotechnology 60
Bio-Manguinhos 61
Clinical Trial Overview of Bio-Manguinhos 61
Yale University 62
Clinical Trial Overview of Yale University 62
Memorial Sloan Kettering Cancer Center 63
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 63
Five Key Clinical Profiles 64
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94

List of Tables
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bordetella Pertussis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bordetella Pertussis Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bordetella Pertussis Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bordetella Pertussis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bordetella Pertussis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bordetella Pertussis Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Bordetella Pertussis Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bordetella Pertussis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 39
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 45
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2014* 47
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by PT Bio Farma, 2014* 48
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2014* 49
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014* 50
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 51
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 52
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell N.V., 2014* 53
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 54
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute for Public Health and the Environment, 2014* 55
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalhousie University, 2014* 56
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2014* 57
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2014* 58
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Institute for Communicable Disease Control, 2014* 59
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Genetic Engineering and Biotechnology, 2014* 60
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Manguinhos, 2014* 61
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 62
Bordetella Pertussis Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 63

List of Figures
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bordetella Pertussis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bordetella Pertussis Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bordetella Pertussis Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bordetella Pertussis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bordetella Pertussis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bordetella Pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bordetella Pertussis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bordetella Pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bordetella Pertussis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bordetella Pertussis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bordetella Pertussis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 93

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[百日咳菌感染症(Bordetella Pertussis Infections):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆